As a control, we analyzed DINO expression in the HPV-negative C33A cervical carcinoma line that expresses a DNA binding-defective TP53 cancer hot spot mutant where the arginine residue at position 273 is changed to a histidine (R273H) (45, –, 47). This evidence concerns the gene TP53 and cervical carcinoma.